Literature DB >> 11782555

Toll-like receptors.

Egil Lien1, Robin R Ingalls.   

Abstract

The ability of a host to sense invasion by pathogenic organisms and to respond appropriately to control infection is paramount to survival. In the case of sepsis and septic shock, however, an exaggerated systemic response may, in fact, contribute to the morbidity and mortality associated with overwhelming infections. The innate immune system has evolved as the first line of defense against invading microorganisms. The Toll-like receptors (TLRs) are a part of this innate immune defense, recognizing conserved patterns on microorganisms. These TLRs and their signaling pathways are represented in such diverse creatures as mammals, fruit flies, and plants. Ten members of the TLR family have been identified in humans, and several of them appear to recognize specific microbial products, including lipopolysaccharide, bacterial lipoproteins, peptidoglycan, and bacterial DNA. Signals initiated by the interaction of TLRs with specific microbial patterns direct the subsequent inflammatory response. Thus, TLR signaling represents a key component of the innate immune response to microbial infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782555

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  28 in total

Review 1.  [End-organ damage in inflammation and sepsis].

Authors:  U Müller-Werdan; K Werdan
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

2.  The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms.

Authors:  Athanasios N Athanasopoulos; Matina Economopoulou; Valeria V Orlova; Astrid Sobke; Darius Schneider; Holger Weber; Hellmut G Augustin; Sabine A Eming; Uwe Schubert; Thomas Linn; Peter P Nawroth; Muzaffar Hussain; Hans-Peter Hammes; Mathias Herrmann; Klaus T Preissner; Triantafyllos Chavakis
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

3.  Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.

Authors:  G Pedersen; L Andresen; M W Matthiessen; J Rask-Madsen; J Brynskov
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

4.  Toll-like receptor-2 has a critical role in periodontal pathogen-induced myocardial fibrosis in the pressure-overloaded murine hearts.

Authors:  Makoto Kaneko; Jun-Ichi Suzuki; Norio Aoyama; Ryo Watanabe; Asuka Yoshida; Yuka Shiheido; Yuichi Izumi; Mitsuaki Isobe
Journal:  Hypertens Res       Date:  2016-09-01       Impact factor: 3.872

5.  The effect of aerosolized and intravenously administered clenbuterol and aerosolized fluticasone propionate on horses challenged with Aspergillus fumigatus antigen.

Authors:  T T J M Laan; S Bull; R A van Nieuwstadt; J Fink-Gremmels
Journal:  Vet Res Commun       Date:  2006-08       Impact factor: 2.459

6.  Porphyromonas gingivalis promotes neointimal formation after arterial injury through toll-like receptor 2 signaling.

Authors:  Naho Kobayashi; Jun-ichi Suzuki; Masahito Ogawa; Norio Aoyama; Issei Komuro; Yuichi Izumi; Mitsuaki Isobe
Journal:  Heart Vessels       Date:  2013-09-04       Impact factor: 2.037

7.  Differential expression of toll-like receptors in the human placenta across early gestation.

Authors:  Jeffrey Pudney; Xianbao He; Zahrah Masheeb; David W Kindelberger; Wendy Kuohung; Robin R Ingalls
Journal:  Placenta       Date:  2016-07-26       Impact factor: 3.481

8.  Beneficial or deleterious effects of a preexisting hypersensitivity to bacterial components on the course and outcome of infection.

Authors:  Marina Gumenscheimer; Ivan Mitov; Chris Galanos; Marina A Freudenberg
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Biological activities of Bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease.

Authors:  Akira Hasebe; Atsutoshi Yoshimura; Takeshi Into; Hideo Kataoka; Saori Tanaka; Shinichi Arakawa; Hiroaki Ishikura; Douglas T Golenbock; Tsutomu Sugaya; Nobuo Tsuchida; Masamitsu Kawanami; Yoshitaka Hara; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 10.  Severe sepsis and Toll-like receptors.

Authors:  Hongmei Gao; Susannah K Leaver; Anne Burke-Gaffney; Simon J Finney
Journal:  Semin Immunopathol       Date:  2007-12-11       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.